SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Auric Goldfinger's Short List

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sir Auric Goldfinger who wrote (8001)7/23/2001 11:08:24 AM
From: Sir Auric Goldfinger  Read Replies (1) of 19428
 
PolyMedica Shares Plunge After NYSE Reversal on Listing Stock

Woburn, Massachusetts, July 23 (Bloomberg) -- Shares of
PolyMedica Corp. fell as much as 33 percent after the biggest
maker of diabetes test kits said its shares won't be listed on the
New York Stock Exchange as it previously announced.
Shares of the Woburn, Massachusetts-based company fell $10.73
to $36.80 in midmorning trading, after dropping as low as $32.
The New York Stock Exchange told PolyMedica Friday morning
that it changed its decision to list the shares and didn't give
the company a reason, PolyMedica said in a statement released
after the close of U.S. markets Friday. Trading of PolyMedica
shares was halted Friday pending the announcement.
PolyMedica is trying to find out why the exchange changed its
position, said spokeswoman Sylvia Dresner.
The company had announced July 9 that it expected to switch
to the NYSE from the Nasdaq National Market beginning today.
The NYSE said it would consider a new application, PolyMedica
said.

--Catherine Dodge in the Princeton newsroom (609) 279-4026, or at
cdodge1@bloomberg.net / mfr
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext